Efficacy and safety of infliximab: A comparison with other biological disease-modifying anti-rheumatic drugs.
Daisuke KobayashiSatoshi ItoChinatsu TakaiEriko HasegawaYumi NomuraHiroshi OtaniAsami AbeHajime IshikawaAkira MurasawaIchiei NaritaKiyoshi NakazonoPublished in: Modern rheumatology (2017)
Intensification of IFX was effective and well tolerated for MTX resistant patients.